MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9

Molecular Medicine Reports

Volumn 11, Issue 6, 2015, Pages 4115-4120

  Han, Tong ^a   Yi, Xiao Ping ^a   Liu, Bo ^a   Ke, Mu Jing ^a   Li, Yi Xiong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Developmentally downregulated 9; Invasion; MicroRNA 145; Migration; Neural precursor cell expressed; Pancreatic cancer

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; MESSENGER RNA; MICRORNA; MICRORNA LET 7; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN145 MICRORNA, HUMAN; NEDD9 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BIOINFORMATICS; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HAMARTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY CYST; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RNA SEQUENCE; TRANSITIONAL CELL CARCINOMA; UPREGULATION; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS;

EID: 84924709841     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3294     Document Type: Article

References (26)

1. Muniraj T, Jamidar PA and Aslanian HR: Pancreatic cancer: a comprehensive review and update. Dis Mon 59: 368-402, 2013.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297, 2004.
3. Xi JJ: MicroRNAs in Cancer. Cancer Treat Res 158: 119-137, 2013.
4. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
5. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
6. Wang Z: Advances with microRNAs in tumorigenesis and cancer therapy. Curr Pharm Des 20: 5245, 2014.
7. Xing AY, Wang B, Shi DB, et al: Deregulated expression of miR 145 in manifold human cancer cells. Exp Mol Pathol 95: 91-97, 2013.
8. Wu H, Xiao Z, Wang K, Liu W and Hao Q: MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. Biochem Biophys Res Commun 441: 693-700, 2013.
9. Fuse M, Nohata N, Kojima S, et al: Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int J Oncol 38: 1093-1101, 2011.
10. Chiyomaru T, Enokida H, Tatarano S, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
11. Cho WC, Chow AS and Au JS: Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 45: 2197-2206, 2009.
12. Wang S, Bian C, Yang Z, et al: miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol 34: 1461-1466, 2009.
13. Mees ST, Schleicher C, Mardin WA, Senninger N, Colombo-Benkmann M and Haier J: Analyzing miRNAs in ductal adenocarcinomas of the pancreas. J Surg Res 169: 241-246, 2011.
14. Papaconstantinou IG, Manta A, Gazouli M, et al: Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas 42: 67-71, 2013.
15. O'Neill GM, Seo S, Serebriiskii IG, Lessin SR and Golemis EA: A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 67: 8975-8979, 2007.
16. Izumchenko E, Singh MK, Plotnikova OV, et al: NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res 69: 7198-7206, 2009.
17. Lai EC: Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30: 363-364, 2002.
18. Iorio MV and Croce CM: MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856, 2009.
19. Szafranska AE, Davison TS, John J, et al: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26: 4442-4452, 2007.
20. Lee EJ, Gusev Y, Jiang J, et al: Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054, 2007.
21. Seo S, Ichikawa M and Kurokawa M: Structure and function of cas-L and integrin-mediated signaling. Crit Rev Immunol 26: 391-406, 2006.
22. Singh MK, Izumchenko E, Klein-Szanto AJ, Egleston BL, Wolfson M and Golemis EA: Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9. Cancer Res 70: 8907-8916, 2010.
23. Chang JX, Gao F, Zhao GQ and Zhang GJ: Expression and clinical significance of NEDD9 in lung tissues. Med Oncol 29: 2654-2660, 2012.
24. Kim M, Gans JD, Nogueira C, et al: Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125: 1269-1281, 2006.
25. Speranza MC, Frattini V, Pisati F, et al: NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 3: 723-734, 2012.
26. Xue YZ, Sheng YY, Liu ZL, et al: Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance. Tumour Biol 34: 895-899, 2013.